Chen, Wei
Li, Qixuan
Zhang, Heng
Sun, Kangkang
Sun, Wei
Jiao, Zhuqing
Ni, Xinye
Funding for this research was provided by:
National Natural Science Foundation of China (62371243, 62371243, 62371243, 62371243, 62371243)
Jiangsu Provincial Medical Key Discipline Construction Unit (Oncology Therapeutics (JSDW202237, JSDW202237, JSDW202237, JSDW202237, JSDW202237)
Social Development Project of Jiangsu Provincial Key Research & Development Plan (BE2022720, BE2022720, BE2022720, BE2022720, BE2022720)
General Project of Jiangsu Provincial Health Commission (M2020006, M2020006, M2020006, M2020006, M2020006)
Article History
Received: 25 December 2023
Accepted: 10 June 2024
First Online: 8 July 2024
Declarations
:
: The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the ethics committee of the Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University (approval number: [2020]KY154-01) and waived the requirement for written informed consent from patients.
: Not applicable.
: The authors declare that they have no conflicts of interest, and manuscript is approved by all authors for publication.